dapagliflozin
astrazeneca
['cardio']
#esccongress | #deliver trial confirms the benefit of #sglt2i in reducing cardiovascular death and hf hospitalization among patients with #hfpef and #hfmref. #esc2022 #heartfailure 
Resident Physician in Cardiology, Alma Mater Studiorum - University of Bologna, Italy ????